Nutritional supplements for patients being treated for active visceral leishmaniasis.

ABSTRACT:

Background

Visceral leishmaniasis (VL) is a disease caused by a parasite, which can lead to death if untreated. Poor nutritional status hastens the progression of VL infection, and VL worsens malnutrition status. Malnutrition is one of the poor prognostic factors identified for leishmaniasis. However, the effects of nutritional supplementation in people treated for VL are not known.

Objectives

To assess the effects of oral nutritional supplements in people being treated with anti-leishmanial drug therapy for VL.

Search methods

We searched the Cochrane Infectious Diseases Group (CIDG) Specialized Register, CENTRAL, MEDLINE, Embase, LILACS, and two trial registers up to 12 September 2017. We checked conference proceedings and WHO consultative meeting reports, the refere

SUBMITTER: Custodio E 

PROVIDER: S-EPMC6494195 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature